EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma

Medical Oncology

Volumn 30, Issue 1, 2013, Pages

  Wu, Mengyan ^a   Liu, Yingxia ^a   Di, Xiaoqing ^a   Kang, Haixian ^a   Zeng, Hua ^a   Zhao, Yi ^a   Cai, Kangrong ^a   Pang, Tianyun ^a   Wang, Sen ^a   Yao, Yunhong ^a   Hu, Xinrong ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

c Myc; eIF4E; MMP9; NPC; siRNAs

Indexed keywords

GELATINASE B; INITIATION FACTOR 4E; MYC PROTEIN;

ARTICLE; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINOPHARYNGITIS;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84871570209     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0400-z     Document Type: Article

References (24)

1. Joshi B, et al. Characterization of mammalian eIF4E-family members. Eur J Biochem. 2004;271:2189-203.
2. Li Y, et al. Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer. Cancer Biol Ther. 2012;13:272-80.
3. Avdulov S, et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell. 2004;5:553-63.
4. Robalino J, et al. Two zebrafish eIF4E family members are differentially expressed and functionally divergent. J Biol Chem. 2004;279:10532-41.
5. Lazaris-Karatzas A, et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature. 1990;345:544-7.
6. PolunoVSky VA, et al. The cap-dependent translation apparatus integrates and amplifies cancer pathways. RNA Biol. 2006;3:10-7.
7. Sonenberg N. eIF4E, the mRNA cap-binding protein: from basic discovery to translational research. Biochem Cell Biol. 2008;86:178-83.
8. Larsson O, et al. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res. 2007;67:6814-24.
9. Flowers A, et al. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome. Surgery. 2009;146:220-6.
10. Anthony B, et al. Overexpression of the proto-oncogene/translation factor 4E in breast-carcinoma cell lines. Int J Cancer. 1996;65:858-63.
11. Chen CN, et al. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome. J Surg Oncol. 2004;86:22-7.
12. Wang R, et al. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma. Lung Cancer. 2009;66:237-44.
13. Walsh D, et al. Increased levels of the translation initiation factor eIF4E in differentiating epithelial lung tumor cell lines. Differentiation. 2003;71:126-34.
14. Sorrells DL Jr, et al. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. J Oral Maxillofac Surg. 1999;57:294-9.
15. Nathan CO, et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Clin Cancer Res. 2004;10:5820-7.
16. Nasr Z, et al. eIF4F suppression in breast cancer affects maintenance and progression. Oncogene. 2012;. doi: 10.1038/onc.2012.105.
17. Oridate N, et al. Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin. Cancer Biol Ther. 2005;4:318-23.
18. DeFatta RJ, et al. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line. Laryngoscope. 2000;110:928-33.
19. Abdulamir AS, et al. The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types. BMC Public Health. 2008;8:400-15.
20. Yu MC, et al. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421-9.
21. Wang XL, et al. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma. World J Gastroenterol. 2012;18:2540-4.
22. Lin CJ, et al. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res. 2008;68:5326-34.
23. Fan CS, et al. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol. 2000;31:169-78.
24. Liu Z, et al. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer. 2010;10:270-6.